Ascorbic acidAcute oxalate nephropathy due to off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1830卷 / 1期

关键词：

D O I：

10.1007/s40278-020-86014-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：64 / 64

相关论文

共 50 条

[21] Ascorbic-acid overdoseAcute kidney injury and oxalate nephropathy: case report
Reactions Weekly, 2023, 1956 (1) : 77 - 77
[22] Ascorbic-acid/vitamin-dHypercalciuria and oxalate nephropathy: case report
Reactions Weekly, 2021, 1880 (1) : 70 - 70
[23] Ascorbic acid/dexamethasone/zincLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1935 (1) : 94 - 94
[24] Ascorbic-acid/favipiravir/methylprednisoloneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1932 (1) : 105 - 105
[25] Case report: Acute oxalate nephropathy due to traditional medicinal herbs
Wang, Lirui
Zhu, Zhuxian
Li, Jiangtao
FRONTIERS IN MEDICINE, 2022, 9
[26] Acute oxalate nephropathy due to yellow rice wine: a case report
Chen, Xi
Shen, Jie
Liu, Yuxue
Ran, Yingchun
Chen, Mindong
Zhou, Rong
BMC NEPHROLOGY, 2025, 26 (01)
[27] Multiple drugsBK-virus-associated nephropathy and off-label use: case report
Reactions Weekly, 2020, 1832 (1) : 210 - 210
[28] RituximabPneumocystosis and off label use: case report
Reactions Weekly, 2022, 1920 (1) : 419 - 419
[29] MethylprednisoloneAspergillosis and off label use: case report
Reactions Weekly, 2023, 1954 (1) : 281 - 281
[30] TocilizumabTransaminitis and off label use: case report
Reactions Weekly, 2023, 1953 (1) : 365 - 365

← 1 2 3 4 5 →